Ancora Advisors’s Mesoblast MESO Stock Holding History

Ancora Advisors’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-750	Closed	-$8K	–	901
2016 Q4	$8K	Buy	+750	New	+$6.97K	﹤0.01%	1072

Other funds holding MESO

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCMI

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

OWD

Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $7.29B AUM 16.22% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Ancora Advisors's MESO Position: Q1 2017 in Review

Ancora Advisors sold out of Mesoblast (MESO) in Q1 2017, closing a stake of 750 shares — an estimated $8K sold.

Ancora Advisors first reported a position in MESO in Q4 2016 and held it in 1 quarter. The position peaked at $8K in Q4 2016. 13 funds tracked by Wall St. Rank hold MESO as of Q1 2017.

Ancora Advisors reported no remaining Mesoblast position as of Q1 2017 after selling out during the quarter.
Ancora Advisors sold 750 Mesoblast shares in Q1 2017, an estimated $8K.
Ancora Advisors first reported a position in Mesoblast in Q4 2016 and held it in 1 quarter.
Ancora Advisors's Mesoblast position peaked at $8K in Q4 2016.
13 funds tracked by Wall St. Rank held Mesoblast as of Q1 2017.

Based on Ancora Advisors's 13F filing for Q1 2017, filed 15 May 2017.